Covid-19 Impact on Point of Care Testing Market, Global Research Reports 2020-2021

2 Global Point of Care Testing Quarterly Market Size Analysis

• 2.1 Point of Care Testing Business Impact Assessment - COVID-19
  • 2.1.1 Global Point of Care Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Point of Care Testing Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Point of Care Testing Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Point of Care Testing Headquarters and Area Served
• 3.3 Date of Key Players Enter into Point of Care Testing Market
• 3.4 Key Players Point of Care Testing Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Point of Care Testing Segments, By Type

• 4.1 Introduction
  • 1.4.1 Blood Glucose Test
  • 1.4.2 Pregnancy Test
  • 1.4.3 Infectious Factor Test
  • 1.4.4 Cardiac Marker Test
  • 1.4.5 Blood Chemistry Test
  • 1.4.6 Others
• 4.2 By Type, Global Point of Care Testing Market Size, 2019-2021

5 Impact of Covid-19 on Point of Care Testing Segments, By Application

• 5.1 Overview
  • 5.5.1 Hosptial
  • 5.5.2 Home Care
• 5.2 By Application, Global Point of Care Testing Market Size, 2019-2021
  • 5.2.1 By Application, Global Point of Care Testing Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Roche Diagnostics
  • 7.1.1 Roche Diagnostics Business Overview
  • 7.1.2 Roche Diagnostics Point of Care Testing Quarterly Revenue, 2020
  • 7.1.3 Roche Diagnostics Point of Care Testing Product Introduction
  • 7.1.4 Roche Diagnostics Response to COVID-19 and Related Developments
• 7.2 Radiometer
  • 7.2.1 Radiometer Business Overview
  • 7.2.2 Radiometer Point of Care Testing Quarterly Revenue, 2020
  • 7.2.3 Radiometer Point of Care Testing Product Introduction
  • 7.2.4 Radiometer Response to COVID-19 and Related Developments
• 7.3 Beckman
  • 7.3.1 Beckman Business Overview
  • 7.3.2 Beckman Point of Care Testing Quarterly Revenue, 2020
  • 7.3.3 Beckman Point of Care Testing Product Introduction
  • 7.3.4 Beckman Response to COVID-19 and Related Developments
• 7.4 Abbott
  • 7.4.1 Abbott Business Overview
  • 7.4.2 Abbott Point of Care Testing Quarterly Revenue, 2020
  • 7.4.3 Abbott Point of Care Testing Product Introduction
  • 7.4.4 Abbott Response to COVID-19 and Related Developments
• 7.5 Siemens Healthcare Diagnostics
  • 7.5.1 Siemens Healthcare Diagnostics Business Overview
  • 7.5.2 Siemens Healthcare Diagnostics Point of Care Testing Quarterly Revenue, 2020
  • 7.5.3 Siemens Healthcare Diagnostics Point of Care Testing Product Introduction
  • 7.5.4 Siemens Healthcare Diagnostics Response to COVID-19 and Related Developments
• 7.6 Johnson & Johnson
  • 7.6.1 Johnson & Johnson Business Overview
  • 7.6.2 Johnson & Johnson Point of Care Testing Quarterly Revenue, 2020
  • 7.6.3 Johnson & Johnson Point of Care Testing Product Introduction
  • 7.6.4 Johnson & Johnson Response to COVID-19 and Related Developments
• 7.7 Alfa Wassermann
  • 7.7.1 Alfa Wassermann Business Overview
  • 7.7.2 Alfa Wassermann Point of Care Testing Quarterly Revenue, 2020
  • 7.7.3 Alfa Wassermann Point of Care Testing Product Introduction
  • 7.7.4 Alfa Wassermann Response to COVID-19 and Related Developments
• 7.8 Nova Biomedical
  • 7.8.1 Nova Biomedical Business Overview
  • 7.8.2 Nova Biomedical Point of Care Testing Quarterly Revenue, 2020
  • 7.8.3 Nova Biomedical Point of Care Testing Product Introduction
  • 7.8.4 Nova Biomedical Response to COVID-19 and Related Developments
• 7.9 Alere
  • 7.9.1 Alere Business Overview
  • 7.9.2 Alere Point of Care Testing Quarterly Revenue, 2020
  • 7.9.3 Alere Point of Care Testing Product Introduction
  • 7.9.4 Alere Response to COVID-19 and Related Developments
• 7.10 Accriva
  • 7.10.1 Accriva Business Overview
  • 7.10.2 Accriva Point of Care Testing Quarterly Revenue, 2020
  • 7.10.3 Accriva Point of Care Testing Product Introduction
  • 7.10.4 Accriva Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US